Wedbush Securities Inc Arcturus Therapeutics Holdings Inc. Transaction History

Wedbush Securities Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$17.64 - $39.57 $104,834 - $235,164	-5,943 Closed	0 $0
Q4 2021 Jan 13, 2022	SELL	$34.2 - $47.56 $399,524 - $555,595	-11,682 Reduced 66.28%	5,943 $219,000
Q3 2021 Oct 08, 2021	SELL	$27.88 - $58.25 $167 - $349	-6 Reduced 0.03%	17,625 $842,000
Q2 2021 Jul 27, 2021	SELL	$25.79 - $42.11 $217,461 - $355,071	-8,432 Reduced 32.35%	17,631 $596,000
Q1 2021 Apr 26, 2021	BUY	$38.75 - $86.92 $1.01 Million - $2.27 Million	26,063 New	26,063 $1.08 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.